mgl-3196 and Hyperlipoproteinemia-Type-II

mgl-3196 has been researched along with Hyperlipoproteinemia-Type-II* in 1 studies

1 other study(ies) available for mgl-3196 and Hyperlipoproteinemia-Type-II

Article	Year
Resmetirom (MGL-3196) in Patients With Heterozygous Familial Hypercholesterolemia. Journal of the American College of Cardiology, 2022, 03-29, Volume: 79, Issue:12 Topics: Heterozygote; Humans; Hyperlipoproteinemia Type II; Pyridazines; Uracil	2022